Harel Insurance Investments & Financial Services Ltd. Sells 94,142 Shares of Amdocs Limited (NASDAQ:DOX)

Harel Insurance Investments & Financial Services Ltd. lessened its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 29.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 228,320 shares of the technology company's stock after selling 94,142 shares during the quarter. Harel Insurance Investments & Financial Services Ltd. owned about 0.19% of Amdocs worth $20,166,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC raised its holdings in Amdocs by 1.5% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 4,962,197 shares of the technology company's stock worth $419,256,000 after acquiring an additional 75,733 shares during the period. Invesco Ltd. grew its position in Amdocs by 31.0% in the 3rd quarter. Invesco Ltd. now owns 2,629,346 shares of the technology company's stock worth $222,153,000 after purchasing an additional 621,962 shares during the last quarter. Nordea Investment Management AB grew its position in Amdocs by 1.9% in the 3rd quarter. Nordea Investment Management AB now owns 2,109,185 shares of the technology company's stock worth $180,905,000 after purchasing an additional 38,452 shares during the last quarter. American Century Companies Inc. grew its position in Amdocs by 6.2% in the 3rd quarter. American Century Companies Inc. now owns 1,980,219 shares of the technology company's stock worth $167,309,000 after purchasing an additional 115,744 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its position in Amdocs by 8.1% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,861,430 shares of the technology company's stock worth $178,753,000 after purchasing an additional 139,026 shares during the last quarter. Institutional investors own 92.02% of the company's stock.


Analyst Upgrades and Downgrades

DOX has been the topic of several recent research reports. StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Friday, March 15th. Citigroup boosted their target price on shares of Amdocs from $96.00 to $104.00 and gave the stock a "buy" rating in a research note on Wednesday, January 17th. Finally, Barclays boosted their target price on shares of Amdocs from $105.00 to $115.00 and gave the stock an "overweight" rating in a research note on Thursday, February 8th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $108.60.

View Our Latest Report on DOX

Amdocs Trading Down 1.9 %

Shares of DOX traded down $1.63 on Friday, reaching $85.71. 493,410 shares of the company's stock were exchanged, compared to its average volume of 660,144. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.21. The stock has a market capitalization of $10.07 billion, a P/E ratio of 18.35, a price-to-earnings-growth ratio of 1.39 and a beta of 0.69. The business has a 50 day moving average price of $90.61 and a two-hundred day moving average price of $87.25. Amdocs Limited has a 12 month low of $78.38 and a 12 month high of $99.75.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings results on Tuesday, February 6th. The technology company reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.40 by $0.16. The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. Amdocs's revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.33 earnings per share. Research analysts anticipate that Amdocs Limited will post 5.87 earnings per share for the current year.

Amdocs Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be issued a dividend of $0.479 per share. This is a boost from Amdocs's previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $1.92 annualized dividend and a yield of 2.24%. Amdocs's dividend payout ratio is presently 40.90%.

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

See Also

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

→ Trump’s last act as President (From Porter & Company) (Ad)

Should you invest $1,000 in Amdocs right now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: